According to research published in Addiction, needle and syringe programs are a highly cost-effective means of preventing hepatitis C transmission among people who inject drugs. Investment in such programming, the results show, could save millions of pounds in treatment costs in the United Kingdom (UK). Using data from three UK cities, the researchers estimated the…
Tag: drug use
News: Europe’s hepatitis challenge
An article published in the Bulletin of the World Health Organization (WHO) this month looks at the factors slowing progress in preventing and treating hepatitis B and C infections in Europe. Experts consulted highlight vaccination, voluntary testing, policy development, a focus on high-risk groups like intravenous drug users, standardized data collection, and service integration as…
Microelimination.org: resources for individuals and organizations interested in hepatitis C microelimination 